Amy Moss Trombly Sonoma Pharmaceuticals, Inc. (SNOA) insider trading activity
Amy Moss Trombly is Chief Executive Officer of Sonoma Pharmaceuticals, Inc.. Currently has a direct ownership of 153,586 shares of SNOA, which is worth approximately $393,180. The most recent transaction as insider was on Jun 20, 2024, when has been sold 53,586 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
154K
0%
3M change
28.11%
12M change
Total Value Held
$393,180
Amy Moss Trombly Transaction History
AMT
Amy Moss Trombly
Chief Executive Officer
Woodstock, GA